Cantor Fitzgerald Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Acrivon Therapeutics Inc (ACRV)
(NASDAQ: ACRV) Delayed: 1.95 +0.10 (5.41%)
Previous Close $1.85    52 Week High
Open $1.90    52 Week Low
Day High $1.99    P/E N/A 
Day Low $1.85    EPS
Volume 758,085